Identifying MRI-Defined Optic Pathway Glioma in NF1 Using Macular OCT and Machine Learning
Purpose: To evaluate whether macular optical coherence tomography (OCT) distinguishes eyes with versus without recorded magnetic resonance imaging (MRI)–defined eye-level optic pathway glioma (OPG) status in neurofibromatosis type 1, and whether longitudinal OCT, visual/clinical variables, optic-nerve, or single-feature OCT add value. Methods: One study eye was selected per participant independently of OPG status. The retrospective cohort included 182 participants (58 OPG-positive and 124 OPG-negative eyes). Six primary feature sets compared baseline and longitudinal macular OCT, with and without clinical/visual variables, plus clinical/visual variables alone and visual acuity (VA) alone. Paired macular versus optic-nerve analyses used 141 participants with at least two paired examination dates. Results: Baseline macular OCT achieved pooled out-of-fold area under the precision–recall curve (PR-AUC) 0.819 and area under the receiver operating characteristic curve (ROC-AUC) 0.870, versus 0.551 and 0.667 for VA alone. Longitudinal summaries and added clinical/visual variables provided no clear gain. Baseline macular and optic-nerve OCT showed similar discrimination in the paired cohort (PR-AUC 0.787 vs. 0.802). Macular ganglion cell complex (GCL++) alone achieved PR-AUC 0.819 and ROC-AUC 0.844. Of 58 OPG-positive eyes, 31 (53.4%) had preserved baseline VA; among participants with preserved VA, baseline macular OCT retained discrimination (PR-AUC 0.701; ROC-AUC 0.831). Conclusions: Macular OCT provided structural information beyond VA and showed similar discrimination to optic-nerve OCT. Longitudinal summaries offered no clear gain over baseline OCT, while GCL++ alone showed strong discrimination. Translational Relevance: Simple macular OCT measures may complement clinical assessment and MRI surveillance but require external validation before clinical use.
Authors
- Joan Gispets
- Ayelet Goldstein (ORCID: https://orcid.org/0000-0003-0794-3653)
- Carlos Fresno Cañada (ORCID: https://orcid.org/0000-0003-0823-5587)
Institutions
- Jerusalem Multidisciplinary College (IL)
- Universitat Politècnica de Catalunya (ES)
Publication Details
- Journal
- Translational Vision Science & Technology
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1167/tvst.15.11.18
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00